Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

Morris MJ, Basch EM, Wilding G, Hussain M, Carducci MA, Higano C, Kantoff P, Oh WK, Small EJ, George D, Mathew P, Beer TM, Slovin SF, Ryan C, Logothetis C, Scher HI.

Clin Genitourin Cancer. 2009 Jan;7(1):51-7. doi: 10.3816/CGC.2009.n.009.

2.
3.

American Society of Clinical Oncology policy statement: oversight of clinical research.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2377-86. Epub 2003 Apr 29.

PMID:
12721281
4.

United States military contributions to the National Cancer Institute.

Sarvis JA, Thompson IM.

Urol Oncol. 2009 Sep-Oct;27(5):558-61. doi: 10.1016/j.urolonc.2009.01.025. Review.

PMID:
19720303
5.

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM.

Urology. 2001 Apr;57(4 Suppl 1):4-27.

PMID:
11295590
6.

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.

7.

Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: introducing the Prostate Cancer Consortium in Europe.

Fizazi K, Abrahamsson PA, Ahlgren G, Bellmunt J, Castellano D, Culine S, de Wit R, Gillessen S, Gschwend JE, Hamdy F, James N, McDermott R, Miller K, Wiegel T, Wirth M, Tombal B.

Eur Urol. 2015 May;67(5):904-12. doi: 10.1016/j.eururo.2014.08.076. Epub 2014 Sep 11.

PMID:
25218582
8.

The anatomy of medical research: US and international comparisons.

Moses H 3rd, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER.

JAMA. 2015 Jan 13;313(2):174-89. doi: 10.1001/jama.2014.15939.

PMID:
25585329
9.

Institutional shared resources and translational cancer research.

De Paoli P.

J Transl Med. 2009 Jun 29;7:54. doi: 10.1186/1479-5876-7-54. Review.

10.

Lessons learned from independent central review.

Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.

Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031.

PMID:
19101138
11.

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ.

J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10.

PMID:
24327669
12.

Army and Air Force leadership in the Prostate Cancer Prevention Trial.

Allerton J, Seay T, Optenberg S, Coltman CA Jr, Higgins B, Thompson I, Lovato L.

Urology. 1998 Apr;51(4A Suppl):64-6.

PMID:
9586599
13.

A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC).

Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard J, Wilkerson M, Herberman RB, Becich MJ; PCABC.

Cancer Inform. 2007 Jun 8;3:255-74.

14.

Impact of NCI-mandated scientific review on protocol development and content.

Ning N, Yan J, Xie XJ, Gerber DE.

J Natl Compr Canc Netw. 2015 Apr;13(4):409-16.

15.

Oncology services: the Department of Defense perspective.

Browne D, Baatz LM, Millard F, Ward FT.

Cancer. 1998 May 15;82(10 Suppl):2010-5.

PMID:
9587099
16.

Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Zaren HA, Nair S, Go RS, Enos RA, Lanier KS, Thompson MA, Zhao J, Fleming DL, Leighton JC, Gribbin TE, Bryant DM, Carrigan A, Corpening JC, Csapo KA, Dimond EP, Ellison C, Gonzalez MM, Harr JL, Wilkinson K, Denicoff AM.

J Oncol Pract. 2013 Mar;9(2):e55-61. doi: 10.1200/JOP.2012.000695.

17.

Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database.

Moul JW, Wu H, Sun L, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D, Rich NM.

Surgery. 2002 Aug;132(2):213-9.

PMID:
12219014
18.

Measuring and improving performance in multicenter research consortia.

Greene SM, Hart G, Wagner EH.

J Natl Cancer Inst Monogr. 2005;(35):26-32.

PMID:
16287882
19.
20.

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Warnecke R, Ford L.

J Natl Cancer Inst. 1993 Dec 1;85(23):1945-50.

PMID:
8230286

Supplemental Content

Support Center